Kairos Pharma, LTD. Business Finance Contracts & Agreements

27 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amended and Restated Securities Purchase Agreement between Kairos Pharma, Ltd. and Purchasers (January 16, 2025)
Purchase Agreements
Kairos Pharma, LTD.
NY
2025
Placement Agent and Advisory Services Agreement between Kairos Pharma, Ltd. and Boustead Securities, LLC
Financing Agreements
Kairos Pharma, LTD.
2025
Kairos Pharma, Ltd. Registration Rights Agreement with Purchasers (January 2025)
Registration Rights Agreements
Kairos Pharma, LTD.
2025
Kairos Pharma, Ltd. Securities Purchase Agreement with Purchasers (January 2025)
Purchase Agreements
Kairos Pharma, LTD.
NY
2025
Purchase Agreement between Helena Global Investment Opportunities I Ltd. and Kairos Pharma, Ltd. dated November 12, 2024
Purchase Agreements
Kairos Pharma, LTD.
NY
2024
Amendment to Officer Loan Agreement between Kairos Pharma Ltd. and Doug Samuelson
Note Agreements
Kairos Pharma, LTD.
2024
Amendment to Officer Loan Agreement between Kairos Pharma Ltd. and John S. Yu
Modification Agreements
Kairos Pharma, LTD.
2024
Amendment to Officer Loan Agreement between Kairos Pharma Ltd. and Neil Bhowmick
Modification Agreements
Kairos Pharma, LTD.
2024
Kairos Pharma, Ltd. Promissory Note to Neil Bhowmick dated April [ ], 2024
Note Agreements
Kairos Pharma, LTD.
CA
2024
Kairos Pharma, Ltd. Investor Rights and Lock-Up Agreement (2022)
Investor Rights Agreements
Kairos Pharma, LTD.
CA
2023
Kairos Pharma, Ltd. Convertible Promissory Note Agreement
Note Agreements
Kairos Pharma, LTD.
NY
2023
Amendment to Exclusive License Agreement between Cedars-Sinai Medical Center and Kairos Pharma, Ltd. (June 17, 2021)
Modification Agreements
Kairos Pharma, LTD.
2023
Amendment to Exclusive License Agreement between Cedars-Sinai Medical Center and Kairos Pharma, Ltd. (Successor to Actcell Biopharma, Inc.)
Modification Agreements
Kairos Pharma, LTD.
2023
Amendment to Exclusive Option Agreement between Cedars-Sinai Medical Center and Enviro Therapeutics, Inc.
Modification Agreements
Kairos Pharma, LTD.
2023
Amendment to Exclusive Option Agreement between Cedars-Sinai Medical Center and Enviro Therapeutics, Inc.
Modification Agreements
Kairos Pharma, LTD.
2023
Share Exchange Agreement among Kairos Pharma, Ltd., Enviro Therapeutics, Inc., and Enviro Shareholders
Exchange Agreements
Kairos Pharma, LTD.
CA
2023
Kairos Pharma, Ltd. Placement Agent Warrant to Purchase Common Stock (Form of Warrant Certificate)
Warrant Agreements
Kairos Pharma, LTD.
NY
2025
Common Stock Purchase Warrant Agreement between Kairos Pharma, Ltd. and Holder (January 2025)
Warrant Agreements
Kairos Pharma, LTD.
2025
Common Stock Purchase Warrant Agreement between Kairos Pharma, Ltd. and Holder (January 2025)
Warrant Agreements
Kairos Pharma, LTD.
2025
Kairos Pharma, Ltd. Prefunded Common Stock Purchase Warrant Agreement with Holder
Warrant Agreements
Kairos Pharma, LTD.
NY
2025
Kairos Pharma, Ltd. Lock-Up Agreement with Investors – January 2025
Waiver Agreements
Kairos Pharma, LTD.
2025
Common Stock Purchase Warrant Agreement between Kairos Pharma, Ltd. and EF Hutton LLC
Warrant Agreements
Kairos Pharma, LTD.
NY
2024
Common Stock Purchase Warrant issued to Boustead Securities, LLC, dated September 17, 2024
Warrant Agreements
Kairos Pharma, LTD.
2024
Underwriting Agreement between Kairos Pharma, Ltd. and Boustead Securities, LLC, Dated September 16, 2024
Underwriting Agreements
Kairos Pharma, LTD.
NY
2024
Common Stock Purchase Warrant Agreement between Kairos Pharma, Ltd. and Boustead Securities, LLC
Warrant Agreements
Kairos Pharma, LTD.
NY
2024
Underwriting Agreement between Kairos Pharma, Ltd. and Boustead Securities, LLC
Underwriting Agreements
Kairos Pharma, LTD.
NY
2024
Kairos Pharma, Ltd. Convertible Note Subscription Agreement with Investors
Subscription Agreements
Kairos Pharma, LTD.
NY
2023